PliaFX® Prime

Download the files in the language of your choice
Instructions for Use
Product Specifications


PliaFX Prime is 100% bone fibers, demineralized to encourage bone formation and healing. The fibers
interlock, allowing the graft to become moldable upon rehydration without the use of a carrier.

  •  100% Bone: Grows more bone than DBMs containing a carrier, as demonstrated in literature 1
  •  Moldable: Conforms to the surgical site
  •  Customizable: Easily mixes with autograft, allograft, and/or fluid of surgeon’s choice
  •  Resists Migration: Interlocking fibers allow graft to remain intact and in place
  •  Convenience: Ambient storage and rapid rehydration
  •  Osteoconductive: Large surface area and interconnected network of demineralized cortical fibers provides a scaffold that promotes cellular attachment and cell spreading 2,3
  •  Osteoinductive Potential: Every lot tested in a rodent model as a final product to ensure osteoinductive potential
  •  Safety: Sterilized using proprietary Allowash XG® technology, providing a sterility assurance level of 10-6 to reduce the risk of disease transmission without compromising the graft’s osteoconductive properties or osteoinductive potential 3,4
Clinical Application

Surgical procedures that require bone void filler

Freeze-Dried Description Sizing
BL-1800-00 Plia fx Prime Shelf Life 4 years 0.5 cc
BL-1800-01 Plia fx Prime Shelf Life 4 years 1.0 cc
BL-1800-02 Plia fx Prime Shelf Life 5 years 2.5 cc
BL-1800-05 Plia fx Prime Shelf Life 5 years 5.0 cc
BL-1800-10 Plia fx Prime Shelf Life 5 years 10.0 cc
  1.  Kay JF, Vaughan LM. Proportional osteoinduction of demineralized bone matrix graft materials. February 2004: AW-0204.1.
  2.  Murphy MB, Suzuki RK, Sand TT, et al. Short term culture of mesenchymal stem cells with commercial osteoconductive carriers provides unique insights into biocompatibility. J Clin. Med. 2013; 2,49-66; doi:10.3390/jcm2030049
  3.  Data on file LifeNet Health, ES-17-111-02
  4.  Eisenlohr LM. “Allograft Tissue Sterilization Using Allowash XG(R).” 2007 Bio-Implants Brief.